MARKETING RESEARCH OF THE DOMESTIC PHARMACEUTICAL MARKET OF ANTIHEMORRHAGIC DRUGS
The article presents the results of marketing research of the domestic pharmaceutical market bthe example of medicines of group B02 - Antihemorrhagic drugs. The analysis of the range of the<sup>y</sup>group of drugs studied and the firm structure of the domestic market has been conducted. It habeen found that the deepest range of the group of drugs studied is observed in medicines containingthe human coagulation factor IX, and medicines containing tranexamic acid. Countries that exportantihemorrhagic drugs to the Ukrainian pharmaceutical market have been determined. The main domestic manufacturers of drugs of the range studied have been also determined. The dynamics of themarket capacity and the price situation have been studied; the markdrugs in Ukraine have been identified. The sources of information f<sup>et positions of antihemorrhagic</sup>or professionals about new drugsof the range studied have been revealed. According to the results of calculations of the liquidity ratioof the price it has been determined that drugs containing aminocaproic acid and drugs containinmenandion are the most available.